Partial
Partially Noncompliant
Patient Risk:
Moderate
Summary
Many high-level claims about indications and CNS-depressant-related sedation precautions align with the provided label. However, several clinically important safety/mechanism/adverse-event and product-availability statements are marked absent_from_label in the provided evaluation, indicating substantial label misalignment risk. Additionally, contraindications and pregnancy-related labeling elements were not evaluated in the provided claim results, limiting full compliance verification.
Category Scores
Accurate Statements
Hydroxyzine HCl is used for anxiety or tension in some patients.
INDICATIONS
Hydroxyzine HCl is prescribed to help with itching (pruritus) from allergic skin conditions.
INDICATIONS
“Hydroxyzine” and “hydroxyzine HCl” refer to the same active medicine.
INDICATIONS, ADVERSE REACTIONS (per provided evaluation)
Hydroxyzine has sedating (calming) effects.
INDICATIONS, PRECAUTIONS
People who need to stay alert for driving or operating machinery should use extra caution when taking hydroxyzine due to sedation.
PRECAUTIONS
People taking other sedating medicines should use extra caution when taking hydroxyzine because it can add to drowsiness.
PRECAUTIONS
Hydroxyzine can interact with other drugs that cause drowsiness (such as sedatives, sleep medicines, or alcohol), which can increase impairment.
PRECAUTIONS
Unsupported Statements
Hydroxyzine blocks histamine (H1) receptors.
Marked absent_from_label in the provided evaluation; no label text supporting this within the supplied sections.
Drowsiness is one of the most common effects of hydroxyzine.
Marked absent_from_label in the provided evaluation; PRECAUTIONS support sedation cautions but the specific 'most common' claim is not supported by provided label sections.
Other possible effects of hydroxyzine include dry mouth, dizziness, and blurred vision.
Marked absent_from_label in the provided evaluation; no provided label content substantiates these specific adverse events.
Side effects of hydroxyzine can be stronger at higher doses.
Marked absent_from_label in the provided evaluation; no provided label text supports this specific dose-response wording.
People with conditions that affect heart rhythm should use extra caution when taking hydroxyzine because some antihistamines can contribute to QT prolongation risk in susceptible patients.
Marked absent_from_label in the provided evaluation; no provided label text addressing QT/QTc or heart-rhythm-specific warnings.
People with liver impairment may need dose adjustments of hydroxyzine depending on the product label.
Marked absent_from_label in the provided evaluation; no provided label text supports hepatic impairment dose adjustments.
Hydroxyzine may interact with medications that affect heart rhythm.
Marked absent_from_label in the provided evaluation; no provided label text addressing rhythm-interaction or QT-related drug interactions.
Hydroxyzine HCl is commonly available as oral tablets and capsules.
Marked absent_from_label in the provided evaluation; DOSAGE section provided does not establish marketed dosage forms.
Hydroxyzine HCl may be available as a syrup in some markets.
Marked absent_from_label in the provided evaluation; not supported by provided label content.
The dosing schedule for hydroxyzine depends on the formulation and indication.
Only partially supported by the provided evaluation (dosage depends on indication; 'formulation' dependency not confirmed by provided label text).
For many oral antihistamine uses, people often notice effects within a few hours.
Marked absent_from_label in the provided evaluation; provided label only states effects usually noted within 15 to 30 minutes after oral administration.
Timing of effects from hydroxyzine varies by dose and formulation.
Marked absent_from_label in the provided evaluation; not supported by provided label text.
Timing of effects from hydroxyzine varies depending on whether it is taken with food.
Marked absent_from_label in the provided evaluation; not supported by provided label text.
In many places, hydroxyzine is a prescription medication.
Marked absent_from_label in the provided evaluation; prescription status is not a labeling claim in the supplied sections.
Availability of hydroxyzine varies by country and product formulation.
Marked absent_from_label in the provided evaluation; not supported by the provided label content.
Contradictions
Important Omissions
Contraindication: hypersensitivity to hydroxyzine; contraindication in early pregnancy (until human early-pregnancy safety data available).
Importance:
High
Boxed warning (if present in the full FDA label).
Importance:
Moderate
Premedication/post-general-anesthesia caution including hydroxyzine potentiating meperidine and barbiturates (with guidance to modify pre-anesthetic adjunctive therapy on an individual basis).
Importance:
Moderate
Specific dosing regimens by indication and age group (mg q.i.d., mg t.i.d./q.i.d., pediatric under/over 6 years, and premedication following general anesthesia dosing including 0.6 mg/kg).
Importance:
Moderate
Safety Assessment
Potential Patient Risk:
Moderate
Although some sedation-related precautions align with the label, multiple safety-relevant claims were not supported by the supplied labeling (e.g., QT/heart-rhythm risk, hepatic impairment dosing) and critical contraindication/pregnancy information was not evaluated/covered in the provided claim set, creating compliance uncertainty for safety labeling.
Regulatory Assessment
| On Label |
No |
| Off-label Discussion |
No |
| Promotes Unapproved Use |
No |
| Hallucination Risk |
Moderate |
Recommendation
Partially Noncompliant
Primary Issue
Several claims are marked absent_from_label (not supported by the provided prescribing information), including specific safety-related assertions (QT/heart rhythm, hepatic impairment), and key contraindication/pregnancy labeling elements were not assessed in the provided results.
Suggested Improvement
Restrict statements to the supplied label-supported content: include the contraindications (hypersensitivity and early pregnancy) and only make mechanistic/adverse-event/interaction/availability/timing claims that are explicitly supported by the provided label sections; avoid unsupported specificity such as 'most common,' dry mouth/dizziness/blurred vision, QT prolongation, or hepatic dose adjustments unless directly present in the label text.